• Open Access

Corrigenda


Ishizone S, Yamauchi K, Kawa S et al. Clinical utility of quantitative RT-PCR targeted to α1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer Science 2006; 97: 119–126.

The Publisher wishes to advise that the above article contained two typographical errors. Corrections are in bold:

Page 122, left column, line 21

Based on the standard curve, levels of α4GnT mRNA ranging from 5 × 101 to 5 × 109 copies/mL were detected in a reaction tube.

Page 123, left column, line 38

As shown in Table 2, more than 74% of pancreatic cancer patients were positive for either α4GnT or CA19-9, and CEA and DU-PAN-1 were found to less frequently detect pancreatic cancer compared with α4GnT and CA19-9.

The Publisher apologizes for any confusion this may have caused.

Matsuo M, Sakurai H, Ueno Y, Ohtani O, Saiki I. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib. Cancer Science 2006; 97: 155–162.

The Publisher wishes to advise that in the above article figure 7 was incorrect. This is the correct figure:

inline image

The Publisher and author apologize for any confusion this may have caused.

Ancillary